Search / Trial NCT06615245

Measuring Attention During Immersive Virtual Reality Distraction

Launched by HUNTER HOFFMAN · Sep 23, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Virtual Reality Distraction

Description

Healthy college student volunteers will participate in a mixed factorial randomized controlled trial studying attention using a divided attention paradigm. Group 1 will perform a simple attention demanding task during No VR for 2 minutes. and they will perform the attention demanding task again during No VR for 2 minutes, again. Group 2 will perform a simple attention demanding task during No VR for 2 minutes and they will perform the attention demanding task again during Low Tech VR for 2 minutes. Group 3 will perform a simple attention demanding task during No VR for 2 minutes and the...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Currently enrolled in a course at the University of Washington Psychology Dept., participating in the University of Washington (UW) Psychology subject pool
  • * Able to read, write and comprehend English
  • * Able to complete study measures
  • * Willing to follow our UW approved instructions
  • * 18 years of age or older
  • Exclusion Criteria:
  • * People who have already previously participated in this same study (e.g., last quarter) are not eligible to participate again.
  • * Not enrolled in a course at the University of Washington Psychology Dept., not participating in the UW Psychology subject pool
  • * Not be able to read, write and comprehend English
  • * Younger than 18 years of age.
  • * Not capable of completing measures
  • * Not capable of indicating pain intensity,
  • * Not capable of filling out study measures,
  • * Extreme susceptibility to motion sickness,
  • * Seizure history,
  • * Unusual sensitivity or lack of sensitivity to pain,
  • * Sensitive skin,
  • * Sensitive feet
  • * Migraines
  • * Diabetes

About Hunter Hoffman

Hunter Hoffman is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on cutting-edge methodologies and a commitment to scientific integrity, Hunter Hoffman collaborates with esteemed research institutions and healthcare professionals to design and conduct rigorous clinical trials. The organization prioritizes patient safety and ethical standards while striving to bring transformative treatments to market. Through its comprehensive approach, Hunter Hoffman aims to contribute significantly to the evolving landscape of healthcare and enhance the quality of life for patients worldwide.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0